BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Giouleme O, Diamantidis MD, Katsaros MG. Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms. World J Gastroenterol 2011; 17(4): 444-448 [PMID: 21274373 DOI: 10.3748/wjg.v17.i4.444]
URL: https://www.wjgnet.com/1007-9327/full/v17/i4/444.htm
Number Citing Articles
1
Po-Ke Hsu, Jing-Yang Huang, Wei-Wen Su, James Cheng-Chung Wei. Type 2 diabetes and the risk of colorectal polypsMedicine 2021; 100(19): e25933 doi: 10.1097/MD.0000000000025933
2
Kazuya Hata, Masaya Kubota, Masahito Shimizu, Hisataka Moriwaki, Toshiya Kuno, Takuji Tanaka, Akira Hara, Yoshinobu Hirose. C57BL/KsJ-db/db-ApcMin/+ Mice Exhibit an Increased Incidence of Intestinal NeoplasmsInternational Journal of Molecular Sciences 2011; 12(11): 8133 doi: 10.3390/ijms12118133
3
Maria Kasdagly, Sridhar Radhakrishnan, Lavanya Reddivari, D.N. Rao Veeramachaneni, Jairam Vanamala. Colon carcinogenesis: Influence of Western diet-induced obesity and targeting stem cells using dietary bioactive compoundsNutrition 2014; 30(11-12): 1242 doi: 10.1016/j.nut.2014.02.016
4
M. Makov, G. Chodick, K. Mohnike, T. Otonkoski, H. Huopio, I. Banerjee, H. Cave, M. Polak, H. T. Christesen, K. Hussain, D. Deleon, C. Stanley, M. Cappa, O. Ramos, D. Zangen, Z. Laron. Congenital hyperinsulinism, neonatal diabetes and the risk of malignancies: an international collaborative study. Preliminary communicationDiabetic Medicine 2015; 32(5): 701 doi: 10.1111/dme.12670
5
Hsin-En Huang, Yi-Ching Yang, Jin-Shang Wu, Ru-Hsueh Wang, Feng-Hwa Lu, Chih-Jen Chang. The relationship between different glycemic statuses and colon polyps in a Taiwanese populationJournal of Gastroenterology 2014; 49(7): 1145 doi: 10.1007/s00535-013-0863-5
6
Saumitra Gajjar, Vivek Bora, Bhoomika M. Patel. Repositioning of simvastatin for diabetic colon cancer: role of CDK4 inhibition and apoptosisMolecular and Cellular Biochemistry 2023; 478(10): 2337 doi: 10.1007/s11010-023-04663-w
7
G. E. C. Sun, B. J. Wells, K. Yip, R. Zimmerman, D. Raghavan, M. W. Kattan, S. R. Kashyap. Gender‐specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitusDiabetes, Obesity and Metabolism 2014; 16(3): 276 doi: 10.1111/dom.12231
8
Dinesh Vyas, Chad C. Garthe, Arpita Vyas. Limitations of Current Timing and Frequency of Screening Colonoscopy and Possible Future DirectionJournal of Laparoendoscopic & Advanced Surgical Techniques 2013; 23(3): 271 doi: 10.1089/lap.2012.0428
9
Fatima Mohsen Mroueh, Mohamed Noureldein, Youssef H. Zeidan, Suzan Boutary, Sara Abou Merhi Irani, Stéphanie Eid, Mary Haddad, Rasha Barakat, Frederic Harb, Joseph Costantine, Rouwaida Kanj, Erik‐Andre Sauleau, Allal Ouhtit, Sami T. Azar, Ali H. Eid, Assaad A. Eid. Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancerThe FASEB Journal 2019; 33(12): 14051 doi: 10.1096/fj.201900396RR
10
Jessica K. Paulus, Christina D. Williams, Furha I. Cossor, Michael J. Kelley, Robert E. Martell. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal CancerCancer Epidemiology, Biomarkers & Prevention 2016; 25(10): 1418 doi: 10.1158/1055-9965.EPI-16-0312
11
Guan-Hua Yu, Shuo-Feng Li, Ran Wei, Zheng Jiang, Eusebio Chiefari. Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic ImplicationsJournal of Diabetes Research 2022; 2022: 1 doi: 10.1155/2022/1747326
12
Patrizia Ferroni, Vincenzo Formica, David Della-Morte, Jessica Lucchetti, Antonella Spila, Roberta D'Alessandro, Silvia Riondino, Fiorella Guadagni, Mario Roselli. Prognostic value of glycated hemoglobin in colorectal cancerWorld Journal of Gastroenterology 2016; 22(45): 9984-9993 doi: 10.3748/wjg.v22.i45.9984
13
Doran Avivi, Menachem Moshkowitz, Elmar Detering, Nadir Arber. The role of low-dose aspirin in the prevention of colorectal cancerExpert Opinion on Therapeutic Targets 2012; 16(sup1): S51 doi: 10.1517/14728222.2011.647810
14
Hsiuying Wang. MicroRNA, Diabetes Mellitus and Colorectal CancerBiomedicines 2020; 8(12): 530 doi: 10.3390/biomedicines8120530
15
A Vasconcelos-dos-Santos, H F B R Loponte, N R Mantuano, I A Oliveira, I F de Paula, L K Teixeira, J C M de-Freitas-Junior, K C Gondim, N Heise, R Mohana-Borges, J A Morgado-Díaz, W B Dias, A R Todeschini. Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathwayOncogenesis 2017; 6(3): e306 doi: 10.1038/oncsis.2017.2
16
Zhuoyu Sun, Lin Liu, Peizhong Peter Wang, Barbara Roebothan, Jin Zhao, Elizabeth Dicks, Michelle Cotterchio, Sharon Buehler, Peter T Campbell, John R Mclaughlin, Patrick S Parfrey. Association of total energy intake and macronutrient consumption with colorectal cancer risk: results from a large population-based case-control study in Newfoundland and Labrador and Ontario, CanadaNutrition Journal 2012; 11(1) doi: 10.1186/1475-2891-11-18
17
Marc Rendell, Halis Kaan Akturk, Sri Harsha Tella. Glargine safety, diabetes and cancerExpert Opinion on Drug Safety 2013; 12(2): 247 doi: 10.1517/14740338.2013.770469
18
Michael Erbach, Hellmut Mehnert, Oliver Schnell. Diabetes and the risk for colorectal cancerJournal of Diabetes and its Complications 2012; 26(1): 50 doi: 10.1016/j.jdiacomp.2011.11.003
19
Yiping Cheng, Junming Han, Qihang Li, Yingzhou Shi, Fang Zhong, Yafei Wu, Zhixiang Wang, Zhongshang Yuan, Xiude Fan, Jiajun Zhao. Metabolic obesity phenotypes: a friend or foe of digestive polyps?—An observational study based on National Inpatient DatabaseMetabolism 2022; 132: 155201 doi: 10.1016/j.metabol.2022.155201
20
Carmine Finelli, Giovanni Tarantino. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?Hepatology International 2013; 7(2): 413 doi: 10.1007/s12072-012-9406-z
21
Mehulkumar K. Kanadiya, Tushar D. Gohel, Madhusudhan R. Sanaka, Prashanthi N. Thota, Jay H. Shubrook. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopyJournal of Diabetes and its Complications 2013; 27(5): 463 doi: 10.1016/j.jdiacomp.2013.04.010
22
Vinicius Kannen, Sergio Britto Garcia, Helga Stopper, Ana Maria Waaga-Gasser. Glucagon-like peptide 2 in colon carcinogenesis: Possible target for anti-cancer therapy?Pharmacology & Therapeutics 2013; 139(1): 87 doi: 10.1016/j.pharmthera.2013.04.007
23
Kruti Patel, Vivek Bora, Bhoomika Patel. Sodium orthovanadate exhibits anti-angiogenic, antiapoptotic and blood glucose-lowering effect on colon cancer associated with diabetesCancer Chemotherapy and Pharmacology 2024; 93(1): 55 doi: 10.1007/s00280-023-04596-7
24
Ian N. Hines, Hadley J. Hartwell, Yan Feng, Elizabeth J. Theve, Gregory A. Hall, Sara Hashway, Jessica Connolly, Michelle Fecteau, James G. Fox, Arlin B. Rogers. Insulin Resistance and Metabolic Hepatocarcinogenesis with Parent-of-Origin Effects in A×B MiceThe American Journal of Pathology 2011; 179(6): 2855 doi: 10.1016/j.ajpath.2011.08.014
25
O. Yu. Kolesnichenko, Yu. Yu. Kolesnichenko, V. V. Pulit, A. V. Martynov, A. Yu. Sotnik, I. A. Khaykina, E. B. Marochkina, L. O. Minushkina, K. V. Pimenova, A. S. Bugakova, E. Yu. Vasilyeva, R. N. Komarov, A. V. Golovanov. Big Data Analytics of EHRs: pathogenic relations of cancer with Ischaemic Heart Disease and Diabetes MellitusRemedium 2019; (12): 36 doi: 10.21518/1561-5936-2019-12-36-43
26
K. Hata, M. Kubota, M. Shimizu, H. Moriwaki, T. Kuno, T. Tanaka, A. Hara, Y. Hirose. Monosodium glutamate-induced diabetic mice are susceptible to azoxymethane-induced colon tumorigenesisCarcinogenesis 2012; 33(3): 702 doi: 10.1093/carcin/bgr323
27
Aminat O. Oluyemi, Amy R. Welch, Lisa J. Yoo, Erik B. Lehman, Thomas J. McGarrity, Cynthia H. Chuang. Colorectal cancer screening in high‐risk groups is increasing, although current smokers fall behindCancer 2014; 120(14): 2106 doi: 10.1002/cncr.28707
28
Tomas Grega, Gabriela Vojtechova, Monika Gregova, Miroslav Zavoral, Stepan Suchanek. Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal NeoplasiaPhysiological Research 2021; : 509 doi: 10.33549/physiolres.934631
29
J.‐P. Feng, X.‐L. Yuan, M. Li, J. Fang, T. Xie, Y. Zhou, Y.‐M. Zhu, M. Luo, M. Lin, D.‐W. Ye. Secondary diabetes associated with 5‐fluorouracil‐based chemotherapy regimens in non‐diabetic patients with colorectal cancer: results from a single‐centre cohort studyColorectal Disease 2013; 15(1): 27 doi: 10.1111/j.1463-1318.2012.03097.x
30
Keishi Sugimachi, Rui Yamaguchi, Hidetoshi Eguchi, Masami Ueda, Atsushi Niida, Shotaro Sakimura, Hidenari Hirata, Ryutaro Uchi, Yoshiaki Shinden, Tomohiro Iguchi, Kazutoyo Morita, Ken Yamamoto, Satoru Miyano, Masaki Mori, Yoshihiko Maehara, Koshi Mimori. 8q24 Polymorphisms and Diabetes Mellitus Regulate Apolipoprotein A-IV in Colorectal CarcinogenesisAnnals of Surgical Oncology 2016; 23(S4): 546 doi: 10.1245/s10434-016-5374-1
31
Mayur M. Patel, Bhoomika M. Patel. Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: Role of HDAC inhibitionEuropean Journal of Pharmaceutical Sciences 2018; 121: 188 doi: 10.1016/j.ejps.2018.05.026
32
Hyun-Kyung Chung. Letter: The Association between Type 2 Diabetes Mellitus and Colorectal CancerEndocrinology and Metabolism 2011; 26(4): 364 doi: 10.3803/EnM.2011.26.4.364
33
Rui Sun, Jian-Ping Liu, Chang Gao, Ying-Ying Xiong, Min Li, Ya-Ping Wang, Yan-Wei Su, Mei Lin, An-Li Jiang, Ling-Fan Xiong, Yan Xie, Jue-Ping Feng. Two variants on T2DM susceptible gene HHEX are associated with CRC risk in a Chinese populationOncotarget 2016; 7(20): 29770 doi: 10.18632/oncotarget.8865
34
Junichi Kato, Yohei Shirakami, Masahito Shimizu. Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic DrugsGastrointestinal Disorders 2019; 1(2): 273 doi: 10.3390/gidisord1020023
35
Xiaoshan Feng, Ruirui Xuan, Yingchun Dong, Xiaoqin Wu, Yiping Cheng, Zinuo Yuan, Hang Dong, Junming Han, Fang Zhong, Jiajun Zhao, Xiude Fan. Changes in Clinical Manifestations Due to AFLD Retyping Based on the New MAFLD Criteria: An Observational Study Based on the National Inpatient Sample DatabaseDiagnostics 2023; 13(3): 488 doi: 10.3390/diagnostics13030488
36
Chin‐Hsiao Tseng. Diabetes and thyroid cancer mortality: a 12‐year prospective follow‐up of TaiwaneseEuropean Journal of Clinical Investigation 2013; 43(6): 595 doi: 10.1111/eci.12086
37
VINCENZA CONTEDUCA, DOMENICO SANSONNO, SABINO RUSSI, FRANCO DAMMACCO. Precancerous colorectal lesionsInternational Journal of Oncology 2013; 43(4): 973 doi: 10.3892/ijo.2013.2041
38
Jelena Vekic, Aleksandra Zeljkovic, Aleksandra Stefanovic, Rosaria Vincenza Giglio, Marcello Ciaccio, Manfredi Rizzo. Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic AgentsInternational Journal of Molecular Sciences 2021; 22(22): 12409 doi: 10.3390/ijms222212409
39
Shrimahitha Duraiyarasan, Mayowa Adefuye, Nisha Manjunatha, Vinutna Ganduri, Kruthiga Rajasekaran. Colon Cancer and Obesity: A Narrative ReviewCureus 2022;  doi: 10.7759/cureus.27589
40
Chin-Hsiao Tseng. Diabetes, metformin use, and colon cancer: a population-based cohort study in TaiwanEuropean Journal of Endocrinology 2012; 167(3): 409 doi: 10.1530/EJE-12-0369
41
Yun Jung Bae, Sung-Eun Kim, Seong Yeon Hong, Taesun Park, Sang Gyu Lee, Myung-Sook Choi, Mi-Kyung Sung. Time-course microarray analysis for identifying candidate genes involved in obesity-associated pathological changes in the mouse colonGenes & Nutrition 2016; 11(1) doi: 10.1186/s12263-016-0547-x
42
Anurag Sharma, Hanyann Ng, Abhishek Kumar, Kunal Teli, Jeewanjot Randhawa, James Record, Michael Maroules. Colorectal Cancer: Histopathologic Differences in Tumor Characteristics Between Patients With and Without DiabetesClinical Colorectal Cancer 2014; 13(1): 54 doi: 10.1016/j.clcc.2013.10.002
43
Thomas Broughton, Jamie Sington, Ian L. P. Beales. Statin use is associated with a reduced incidence of colorectal adenomatous polypsInternational Journal of Colorectal Disease 2013; 28(4): 469 doi: 10.1007/s00384-012-1601-9
44
祥政 孟. Research Progress on the Relationship between Type 2 Diabetes Mellitus and Colorectal AdenomasWorld Journal of Cancer Research 2024; 14(02): 88 doi: 10.12677/wjcr.2024.142013
45
Shaun V. Walsh, Frank A. Carey. Morson and Dawson's Gastrointestinal Pathology2013; : 685 doi: 10.1002/9781118399668.ch38
46
Jingjing Wu, Huimin He, Qi Zhang, Yan Zhang. Fasting blood glucose was linearly associated with colorectal cancer risk in the population without self-reported diabetes mellitus historyMedicine 2021; 100(34): e26974 doi: 10.1097/MD.0000000000026974
47
Justin Y. Jeon, Duck Hyoun Jeong, Min Geun Park, Ji-Won Lee, Sang Hui Chu, Ji-Hye Park, Mi Kyung Lee, Kaori Sato, Jennifer A. Ligibel, Jeffrey A. Meyerhardt, Nam Kyu Kim, Antonio Moschetta. Impact of Diabetes on Oncologic Outcome of Colorectal Cancer Patients: Colon vs. Rectal CancerPLoS ONE 2013; 8(2): e55196 doi: 10.1371/journal.pone.0055196
48
Hans J. Nielsen, Karen V. Jakobsen, Ib J. Christensen, Nils Brünner. Screening for colorectal cancer: possible improvements by risk assessment evaluation?Scandinavian Journal of Gastroenterology 2011; 46(11): 1283 doi: 10.3109/00365521.2011.610002
49
E. A. Lapteva, A. P. Bykova. Structural and functional features of the colon in patients with non-alcoholic fatty liver disease and comorbid pathologyExperimental and Clinical Gastroenterology 2022; (3): 37 doi: 10.31146/1682-8658-ecg-199-3-37-42
50
Shahzaib Ahmad, Tahseen A. Chowdhury, Barbara J. Boucher. Diabetes and cancer: Could vitamin D provide the link?Journal of Diabetes and its Complications 2013; 27(2): 184 doi: 10.1016/j.jdiacomp.2012.10.005
51
I. V. Druk, E. A. Lyalyukova, E. A. Fadeeva. Metformin in the prevention of colorectal cancer with diabetes mellitusExperimental and Clinical Gastroenterology 2022; (9): 161 doi: 10.31146/1682-8658-ecg-205-9-161-170
52
Sergio Ruiz-Saavedra, Nuria Salazar, Adolfo Suárez, Ylenia Diaz, Carmen González del Rey, Sonia González, Clara G. de los Reyes-Gavilán. Human fecal alpha-glucosidase activity and its relationship with gut microbiota profiles and early stages of intestinal mucosa damageAnaerobe 2024; 87: 102853 doi: 10.1016/j.anaerobe.2024.102853
53
Robin Myte, Sophia Harlid, Anneli Sundkvist, Björn Gylling, Jenny Häggström, Carl Zingmark, Anna Löfgren Burström, Richard Palmqvist, Bethany Van Guelpen. A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancerScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-62129-1
54
HONG CAO, CHUNHUI JIN, DEFANG HUANG, CHAO LIU, DAOQI SUN, CHENG TAN, XIAOMING ZHU, YAJUN FEI. Changes in serum IGF-1 level and tumor VEGF expression in mice with colorectal cancer under hyperglycemic conditionsMolecular Medicine Reports 2013; 7(4): 1361 doi: 10.3892/mmr.2013.1339
55
Saumitra Gajjar, Bhoomika M. Patel. Common targets for a deadly duo of diabetes mellitus and colon cancer: Catching two fish with one wormEuropean Journal of Pharmacology 2021; 893: 173805 doi: 10.1016/j.ejphar.2020.173805
56
Thomas Broughton, Jamie Sington, Ian LP Beales. Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case–control studyBMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-36
57
C. C. Lin, M. S. Lai, W. Y. Shau. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population‐based cohort studyDiabetic Medicine 2015; 32(3): 324 doi: 10.1111/dme.12596
58
Harald zur Hausen. Red meat consumption and cancer: Reasons to suspect involvement of bovine infectious factors in colorectal cancerInternational Journal of Cancer 2012; 130(11): 2475 doi: 10.1002/ijc.27413
59
Luis A. Garcia Rodriguez, Lucia Cea-Soriano, Stefania Tacconelli, Paola Patrignani. Prospects for Chemoprevention of Colorectal NeoplasiaRecent Results in Cancer Research 2013; 191: 67 doi: 10.1007/978-3-642-30331-9_4
60
Niyati R. Shah, Bhoomika M. Patel. Secoisolariciresinol diglucoside rich extract of L. usitatissimum prevents diabetic colon cancer through inhibition of CDK4Biomedicine & Pharmacotherapy 2016; 83: 733 doi: 10.1016/j.biopha.2016.07.041